DB06568ExperimentalSmall molecule
Alpha-hydroxy glycineamide (αHGA) is the active antiviral metabolite of tri-peptide glycyl-prolyl-glycine-amide (GPG-NH2). αHGA inhibits the replication of HIV-1 in vitro by interfering with the capsid formation. It also has an... It also has an effect on viral gp160 envelope protein.
- Primary indication
- Investigated for use/treatment in HIV infection.Curator reviewed
- Also known as
- aHGA · alfaHGA · alpha-HGA · alphaHGA
What you can answer from here — as of April 02, 2025
Which companies are running trials of alpha-Hydroxy glycineamide, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account